AI Portfolio Summary
In 2025 Q4, Seven Fleet Capital Management LP maintained a portfolio of 85 distinct positions. The most significant new addition to the portfolio was CG ONCOLOGY INC, which now represents 47.85% of the total fund value.
Total Positions
85
Quarter
2025 Q4
Top Holding
CGON (47.8%)
Top 10 Concentration
69.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 85
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CGON
CG ONCOLOGY INC
|
Healthcare | 47.85% | — |
#1
Prev: #—
|
9.5 | 1,515,151 | no change |
NEW
|
1,515,151 | $62,909,069 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 4.58% | — |
#2
Prev: #—
|
6.8 | 130,079 | no change |
NEW
|
130,079 | $6,022,658 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 3.99% | — |
#3
Prev: #—
|
6.1 | 65,800 | no change |
NEW
|
65,800 | $5,240,970 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LQDA
LIQUIDIA CORPOR...
|
Healthcare | 2.39% | — |
#4
Prev: #—
|
5.0 | 91,267 | no change |
NEW
|
91,267 | $3,147,799 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 2.32% | — |
#5
Prev: #—
|
4.9 | 568,747 | no change |
NEW
|
568,747 | $3,054,171 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EXEL
EXELIXIS INC
|
Healthcare | 2.29% | — |
#6
Prev: #—
|
4.4 | 68,569 | no change |
NEW
|
68,569 | $3,005,379 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 1.80% | — |
#7
Prev: #—
|
4.2 | 12,955 | no change |
NEW
|
12,955 | $2,366,101 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 1.59% | — |
#8
Prev: #—
|
4.1 | 79,560 | no change |
NEW
|
79,560 | $2,091,632 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 1.46% | — |
#9
Prev: #—
|
4.1 | 54,025 | no change |
NEW
|
54,025 | $1,918,968 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 1.45% | — |
#10
Prev: #—
|
4.1 | 215,172 | no change |
NEW
|
215,172 | $1,906,424 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XNCR
XENCOR INC
|
Healthcare | 1.28% | — |
#11
Prev: #—
|
4.0 | 109,554 | no change |
NEW
|
109,554 | $1,677,272 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 1.17% | — |
#12
Prev: #—
|
4.0 | 55,342 | no change |
NEW
|
55,342 | $1,535,741 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 1.13% | — |
#13
Prev: #—
|
4.0 | 36,894 | no change |
NEW
|
36,894 | $1,490,518 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BLTE
BELITE BIO INC
|
Healthcare | 1.11% | — |
#14
Prev: #—
|
3.9 | 9,161 | no change |
NEW
|
9,161 | $1,465,394 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.04% | — |
#15
Prev: #—
|
3.9 | 70,180 | no change |
NEW
|
70,180 | $1,372,721 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NUVL
NUVALENT INC
|
Healthcare | 0.96% | — |
#16
Prev: #—
|
3.9 | 12,601 | no change |
NEW
|
12,601 | $1,267,535 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.92% | — |
#17
Prev: #—
|
3.9 | 5,670 | no change |
NEW
|
5,670 | $1,209,071 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 0.89% | — |
#18
Prev: #—
|
3.9 | 82,500 | no change |
NEW
|
82,500 | $1,174,800 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 0.89% | — |
#19
Prev: #—
|
3.9 | 25,365 | no change |
NEW
|
25,365 | $1,170,341 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 0.87% | — |
#20
Prev: #—
|
3.8 | 63,343 | no change |
NEW
|
63,343 | $1,150,309 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 0.83% | — |
#21
Prev: #—
|
3.8 | 533,648 | no change |
NEW
|
533,648 | $1,093,978 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 0.82% | — |
#22
Prev: #—
|
3.8 | 1,860 | no change |
NEW
|
1,860 | $1,083,152 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GERN
GERON CORP
|
Healthcare | 0.78% | — |
#23
Prev: #—
|
3.8 | 777,880 | no change |
NEW
|
777,880 | $1,026,802 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 0.75% | — |
#24
Prev: #—
|
3.8 | 4,000 | no change |
NEW
|
4,000 | $986,160 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LONA
ATHIRA PHARMA I...
|
Healthcare | 0.74% | — |
#25
Prev: #—
|
3.8 | 127,951 | no change |
NEW
|
127,951 | $968,589 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 85 holdings